[1] |
Sahyouni R, Goshtasbi K, Mahmoodi A, et al. Chronic subdural hematoma: a historical and clinical perspective[J]. World Neurosurg, 2017, 108: 948-953.
|
[2] |
Ou Y, Dong J, Wu L, et al. The clinical characteristics, treatment, and outcomes of chronic subdural hematoma in young patients[J]. World Neurosurg, 2019, 125: e1241-e1246.
|
[3] |
Iliescu IA. Current diagnosis and treatment of chronic subdural haematomas[J]. J Med Life, 2015, 8(3): 278-284.
|
[4] |
Uno M, Toi H, Hirai S. Chronic subdural hematoma in elderly patients: is this disease benign?[J]. Neurol Med Chir (Tokyo), 2017, 57(8): 402-409.
|
[5] |
Wu X, Li G, Zhao J, et al. Arachnoid cyst-associated chronic subdural hematoma: report of 14 cases and a systematic literature review[J]. World Neurosurg, 2018, 109: e118-e130.
|
[6] |
Yadav YR, Parihar V, Namdev H, et al. Chronic subdural hematoma[J]. Asian J Neurosurg, 2016, 11(4): 330-342.
|
[7] |
Moskala M, Goscinski I, Kaluza J, et al. Morphological aspects of the traumatic chronic subdural hematoma capsule: SEM studies[J]. Microsc Microanal, 2007, 13(3): 211-219.
|
[8] |
姚鹏飞,石鹏飞,荔志云.慢性硬膜下血肿发病机制及治疗研究的进展[J].临床神经外科杂志, 2017, 14(6): 478-480.
|
[9] |
Edlmann E, Giorgi-Coll S, Whitfield PC, et al. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy[J]. J Neuroinflammation, 2017, 14(1): 108.
|
[10] |
Hua C, Zhao G, Feng Y, et al. Role of matrix metalloproteinase-2, matrix metalloproteinase-9, and vascular endothelial growth factor in the development of chronic subdural hematoma[J]. J Neurotrauma, 2016, 33(1): 65-70.
|
[11] |
Lee KS. How to treat chronic subdural hematoma? Past and now[J]. J Korean Neurosurg Soc, 2019, 62(2): 144-152.
|
[12] |
Almenawer SA, Farrokhyar F, Hong C, et al. Chronic subdural hematoma management: a systematic review and meta-analysis of 34,829 patients[J]. Ann Surg, 2014, 259(3): 449-457.
|
[13] |
Peng D, Zhu Y. External drains versus no drains after burr-hole evacuation for the treatment of chronic subdural haematoma in adults[J]. Cochrane Database Syst Rev, 2016, 2016(8): CD011402.
|
[14] |
Yuan Y, Wang QP, Cao YL, et al. Burr hole drainage and burr hole drainage with irrigation to treat chronic subdural hematoma: a systematic review and meta-analysis[J]. Medicine (Baltimore), 2018, 97(33): e11827.
|
[15] |
Wan Y, Xie D, Xue Z, et al. Single versus double burr hole craniostomy in surgical treatment of chronic subdural hematoma: a meta-analysis[J]. World Neurosurg, 2019, 131: e149-e154.
|
[16] |
Thavara BD, Kidangan GS, Rajagopalawarrier B. Comparative study of single burr-hole craniostomy versus twist-drill craniostomy in patients with chronic subdural hematoma[J]. Asian J Neurosurg, 2019, 14(2): 513-521.
|
[17] |
吴俊,许文辉,马铁梁,等.神经内镜血肿清除术与软通道引流术对慢性硬膜下血肿的疗效分析[J].临床神经外科杂志, 2019, 16(6): 492-496.
|
[18] |
Thotakura AK, Marabathina NR. Nonsurgical treatment of chronic subdural hematoma with steroids[J]. World Neurosurg, 2015, 84(6): 1968-1972.
|
[19] |
Thotakura AK, Marabathina NR. The role of medical treatment in chronic subdural hematoma[J]. Asian J Neurosurg, 2018, 13(4): 976-983.
|
[20] |
Zhang Y, Chen S, Xiao Y, et al. Effects of dexamethasone in the treatment of recurrent chronic subdural hematoma[J]. World Neurosurg, 2017, 105: 115-121.
|
[21] |
Kageyama H, Toyooka T, Tsuzuki N, et al. Nonsurgical treatment of chronic subdural hematoma with tranexamic acid[J]. J Neurosurg, 2013, 119(2): 332-327.
|
[22] |
Soleman J, Nocera F, Mariani L. The conservative and pharmacological management of chronic subdural haematoma[J]. Swiss Med Wkly, 2017, 147: w14398.
|
[23] |
Wang D, Li T, Tian Y, et al. Effects of atorvastatin on chronic subdural hematoma: a preliminary report from three medical centers[J]. J Neurol Sci, 2014, 336(1-2): 237-242.
|
[24] |
Li T, Wang D, Tian Y, et al. Effects of atorvastatin on the inflammation regulation and elimination of subdural hematoma in rats[J]. J Neurol Sci, 2014, 341(1-2): 88-96.
|
[25] |
You W, Zhu Y, Wang Y, et al. Prevalence of and risk factors for recurrence of chronic subdural hematoma[J]. Acta Neurochir (Wien), 2018, 160(5): 893-899.
|
[26] |
Schwarz F, Loos F, Dünisch P, et al. Risk factors for reoperation after initial burr hole trephination in chronic subdural hematomas[J]. Clin Neurol Neurosurg, 2015, 138: 66-71.
|
[27] |
Jeong SI, Kim SO, Won YS, et al. Clinical analysis of risk factors for recurrence in patients with chronic subdural hematoma undergoing burr hole trephination[J]. Korean J Neurotrauma, 2014, 10(1): 15-21.
|
[28] |
林晓宁,田新华,孙瑾,等.慢性硬膜下血肿术后复发的危险因素分析[J].中华神经外科杂志, 2019, 35(3): 302-304.
|
[29] |
Adachi A, Higuchi Y, Fujikawa A, et al. Risk factors in chronic subdural hematoma: comparison of irrigation with artificial cerebrospinal fluid and normal saline in a cohort analysis[J]. PLoS One, 2014, 9(8): e103703.
|
[30] |
龚凯,阮士艳,闫凯旋,等.分隔型慢性硬膜下血肿术后复发因素回顾分析[J].中华神经外科疾病研究杂志, 2018, 17(5): 439-442.
|
[31] |
Wakuta N, Abe H, Fukuda K, et al. Feasibility and safety of endoscopic procedure in burr-hole surgery for chronic subdural hematoma in patients of very advanced age[J]. World Neurosurg, 2020, 134: e1037-e1046.
|